Physician profile
Harneet Walia
NPI 1659510618
$18,850.60
in general payments reported to CMS, 2019-2025
17 companies · $4,481 in 2025
The $4,481 reported for 2025 was more than what 90% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2021: $143 · 2022: $1,692 · 2023: $1,975 · 2024: $9,374 · 2025: $4,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $2,748 · Travel and Lodging: $812 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,942.31 |
| Food and Beverage | $2,747.75 |
| Travel and Lodging | $812.05 |
| Education | $328.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $7,740.44 | 2024 | Mounjaro |
| Resmed Corp | $4,242.84 | 2022-2025 | |
| Lilly USA, LLC | $2,367.98 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Jazz Pharmaceuticals INC. | $1,185.45 | 2019-2025 | |
| Inspire Medical Systems, INC. | $1,182.53 | 2019-2025 | Inspire |
| Itamar Medical INC | $714.02 | 2022-2025 | Watchpatone |
| Harmony Biosciences LLC | $430.92 | 2023-2025 | Wakix |
| Noctrix Health, INC. | $276.51 | 2025 | Nidra |
| Novo Nordisk INC | $172.73 | 2023-2024 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $167.82 | 2023-2025 | Watchman Flx, General - Therapies |
| Medtronic, INC. | $149.99 | 2023 | Cobalt Dr Mri Surescan |
| Fisher & Paykel Healthcare INC | $111.72 | 2022-2024 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $28.50 | 2025 | Lumryz |
| Pfizer INC. | $24.48 | 2025 | |
| Merck Sharp & Dohme LLC | $19.56 | 2024 | Verquvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $18.23 | 2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $16.88 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harneet Walia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.